Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    1 - 4 out of 4Page size: 10
    1. 2013
    2. Published

      Functional characterization of Foxp3-specific spontaneous immune responses

      Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In: Leukemia. 27, 12, p. 2332-40 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells

      Munir, S., Andersen, G. H., Woetmann, Anders , Ødum, Niels, Becker, J. C. & Andersen, Mads Hald, Nov 2013, In: Leukemia. 27, 11, p. 2251-3 3 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

      Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In: Cancer Research. 73, 6, p. 1764-76 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

      Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In: OncoImmunology. 2, 4, 9 p., e23991.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 13571778